Rush Street Interactive Inc vs Zimmer Biomet Holdings Inc — how do they compare? Rush Street Interactive Inc trades at $33.46 (market cap $3.55B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 4.9× Rush Street Interactive Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| RSI | ZBH | |
|---|---|---|
Market Cap | $3.55B | $17.36B |
Sector | Technology | Health |
52-Week High | $34.52 | $107.71 |
52-Week Low | $14.55 | $79.58 |
Enterprise Value | $3.23B | $24.40B |
Dividend Yield | — | 1.07% |
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $34.52, up 6.22% over 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q1 2026 EPS of $0.14, beating expectations, and maintains strong revenue growth projections for 2026. Recent expansion into Alberta and positive analyst coverage highlight operational momentum amid a high valuation multiple.
Outlook remains positive with 77% analyst buy ratings and a consensus price target of $30.44, though the stock trades above target. Risks include elevated P/E of 95.59 and net margin pressure at 2.98%. Earnings on July 29, 2026, will be critical for validating growth trajectory amid competitive and regulatory headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →